Alkermes (ALKS) Stock Forecast for 2024, 2025, 2026. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Alkermes (ALKS) Stock Forecast for 2024, 2025, 2026. Sell or Buy?

Updated: September 13, 2024 (18:00)

Sector: Healthcare

The share price of Alkermes plc (ALKS) now

Latest session on the 12th of September for
Alkermes plc is negative
Trading Volume: 1545030
Open: 26.6 /  High: 26.805 /  Low: 26.01
What analysts predict: $34.92
52-week High/Low: $32.88 / $22.01
50-Day Moving Average: $26.46 — support level today
200-Day Moving Average: $26.42 — support level today

Are you interested in Alkermes plc stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Alkermes stock price in 2024, 2025, 2026, 2027, 2028. How much will one Alkermes share be worth in 2024 - 2028?

When should I take profit in Alkermes stock? When should I record a loss on Alkermes stock? What are analysts' forecasts for Alkermes stock? What is the future of Alkermes stock? We forecast Alkermes stock performance using neural networks based on historical data on Alkermes stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Alkermes stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Alkermes shares. This happens once a day.


Historical and forecast chart of Alkermes stock

The chart below shows the historical price of Alkermes stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Alkermes stock price can be found in the table below.

Long-term forecasts by years.

Alkermes plc is an Irish biopharmaceutical company that researches, develops and markets pharmaceutical products used in a variety of therapeutic areas around the world. The company’s products include drugs for the treatment of schizophrenia, schizoaffective, depressive and bipolar disorder, alcohol and opioid addiction, aids to improve walking in adults with multiple sclerosis, and a drug for the treatment of type 2 diabetes. The company serves pharmaceutical wholesalers, specialized pharmacies and distributors.

Alkermes daily forecast for a month

Date Target Pes. Opt. Vol., %
Sep 15 27.10 26.89 27.42 1.97
Sep 16 27.24 26.60 27.49 3.35
Sep 17 26.72 26.08 27.24 4.46
Sep 18 26.92 26.44 27.12 2.57
Sep 19 27.50 27.15 28.13 3.59
Sep 20 28.23 27.63 28.66 3.71
Sep 21 28.07 27.47 28.65 4.29
Sep 22 28.39 28.18 28.66 1.69
Sep 23 28.47 28.28 28.99 2.51
Sep 24 28.16 27.62 28.74 4.04
Sep 25 28.48 27.95 28.66 2.57
Sep 26 28.17 27.86 28.49 2.24
Sep 27 27.87 27.43 28.21 2.84
Sep 28 28.64 27.97 29.08 3.96
Sep 29 29.31 29.05 29.68 2.18
Sep 30 29.23 28.76 29.60 2.93
Oct 01 29.21 28.71 29.50 2.75
Oct 02 28.79 28.45 29.43 3.46
Oct 03 29.04 28.50 29.35 3.00
Oct 04 29.25 29.02 29.75 2.54
Oct 05 29.27 29.03 29.61 2.00
Oct 06 29.02 28.69 29.62 3.22
Oct 07 29.26 28.85 29.79 3.26
Oct 08 29.37 28.91 29.77 2.99
Oct 09 29.36 28.77 29.54 2.69
Oct 10 29.90 29.66 30.56 3.02
Oct 11 30.05 29.41 30.27 2.91
Oct 12 29.58 28.93 29.94 3.50
Oct 13 29.71 29.08 30.22 3.92
Oct 14 29.53 28.99 29.81 2.81

Alkermes Daily Price Targets


Alkermes Stock Forecast 09-15-2024.

Forecast target price for 09-15-2024: $27.10.
Positive dynamics for Alkermes shares will prevail with possible volatility of 1.927%.
Pessimistic target level: 26.89
Optimistic target level: 27.42

Alkermes Stock Forecast 09-16-2024.

Forecast target price for 09-16-2024: $27.24.
Positive dynamics for Alkermes shares will prevail with possible volatility of 3.241%.
Pessimistic target level: 26.60
Optimistic target level: 27.49

Alkermes Stock Forecast 09-17-2024.

Forecast target price for 09-17-2024: $26.72.
Negative dynamics for Alkermes shares will prevail with possible volatility of 4.267%.
Pessimistic target level: 26.08
Optimistic target level: 27.24

Alkermes Stock Forecast 09-18-2024.

Forecast target price for 09-18-2024: $26.92.
Positive dynamics for Alkermes shares will prevail with possible volatility of 2.501%.
Pessimistic target level: 26.44
Optimistic target level: 27.12

Alkermes Stock Forecast 09-19-2024.

Forecast target price for 09-19-2024: $27.50.
Positive dynamics for Alkermes shares will prevail with possible volatility of 3.461%.
Pessimistic target level: 27.15
Optimistic target level: 28.13

Alkermes Stock Forecast 09-20-2024.

Forecast target price for 09-20-2024: $28.23.
Positive dynamics for Alkermes shares will prevail with possible volatility of 3.576%.
Pessimistic target level: 27.63
Optimistic target level: 28.66

ALKS (ALKS) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Oct. 29.73 27.26 30.84 11.63
Nov. 29.28 26.39 30.27 12.82
Dec. 31.72 27.78 34.63 19.77

Alkermes forecast for this year


Alkermes Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $29.7318. Pessimistic: $27.26. Optimistic: $30.84


Alkermes Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $29.2769. Pessimistic: $26.39. Optimistic: $30.27


Alkermes Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $31.7157. Pessimistic: $27.78. Optimistic: $34.63



Alkermes (ALKS) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 28.00 26.66 30.23 11.81
Feb 26.62 23.22 29.15 20.33
Mar 26.07 22.79 28.33 19.55
Apr 28.38 26.69 30.07 11.23
May 27.70 24.12 29.73 18.85
Jun 28.88 26.28 31.78 17.30
Jul 27.70 25.11 29.16 13.89
Aug 29.11 26.84 31.44 14.64
Sep 30.60 29.30 33.25 11.89
Oct 28.78 26.87 30.73 12.57
Nov 31.76 28.52 34.68 17.75
Dec 32.68 29.46 35.79 17.70

Alkermes (ALKS) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 32.29 29.88 33.66 11.25
Feb 37.73 36.12 40.87 11.61
Mar 36.70 34.14 40.01 14.66
Apr 36.89 33.75 38.96 13.36
May 34.88 30.25 37.13 18.52
Jun 36.66 33.04 39.21 15.73
Jul 33.67 32.29 36.07 10.47
Aug 34.41 30.26 38.92 22.25
Sep 32.25 28.96 36.63 20.95
Oct 32.58 29.70 36.29 18.16
Nov 33.91 31.08 36.61 15.11
Dec 37.65 32.72 39.70 17.57

Alkermes information and performance

Alkermes Address

CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, IE

Market Capitalization: 4 444 390 000 $

Market capitalization of the Alkermes plc is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ALKS shares in the company outstanding by the market price of one share.

EBITDA: 354 933 000 $

EBITDA of Alkermes is earnings before interest, income tax and depreciation of assets.

PE Ratio: 11.81

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: -1057.29

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 2.25

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.617
Quarterly Revenue Growth YOY: -0.354
Trailing PE: 11.81

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 12.55

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2.61

Enterprise Value (EV) /Revenue

EV To EBITDA: 10.08

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 164668000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.